You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Serum mesothelin

Showing 1 - 25 of 7,794
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clinical Management of Esophageal Adenocarcinoma (EAC)

Active, not recruiting
  • Esophageal Cancer
  • Adenocarcinoma
  • serum and tissue mesothelin
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 1, 2021

Mesothelin-positive Advanced Malignant Solid Tumors Trial (Anti-mesothelin CAR-T cells)

Not yet recruiting
  • Mesothelin-positive Advanced Malignant Solid Tumors
  • Anti-mesothelin CAR-T cells
  • (no location specified)
Mar 13, 2023

Mesothelin-positive Advanced Malignant Solid Tumors Trial in Hangzhou (UCLM802 Cell Injection (Anti-mesothelin CAR-T cells))

Recruiting
  • Mesothelin-positive Advanced Malignant Solid Tumors
  • UCLM802 Cell Injection (Anti-mesothelin CAR-T cells)
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital Zhejiang University School of Medi
May 11, 2023

Solid Tumor Trial (UCLM802 Cell Injection)

Not yet recruiting
  • Solid Tumor
  • UCLM802 Cell Injection
  • (no location specified)
Mar 7, 2023

Mesothelioma Early Detection by VOCs

Terminated
  • Pleural Mesothelioma
  • +2 more
    • Farmington Hills, Michigan
      Consultants in Sleep and Pulmonary Medicine
    Jan 14, 2022

    Malignant Pleural Disease, Mesothelioma, Metastases Trial in United States (iCasp9M28z T cell infusions, cyclophosphamide,

    Active, not recruiting
    • Malignant Pleural Disease
    • +4 more
    • iCasp9M28z T cell infusions
    • +2 more
    • Basking Ridge, New Jersey
    • +5 more
    Nov 14, 2022

    Mesothelioma Trial run by the National Cancer Institute (NCI) (LMB-100, nab-paclitaxel)

    Completed
    Has Results
    • Mesothelioma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jul 28, 2022

    Tumors With Mesothelin Expression, Epithelioid Mesothelioma, Cholangiocarcinoma, Extrahepatic Trial run by the NCI (LMB-100,

    Active, not recruiting
    Has Results
    • Neoplasms With Mesothelin Expression
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 18, 2022

    Tumors, Pancreatic Tumors Trial run by the NCI (LMB-100, Nab-Paclitaxel, Mesothelin Expression)

    Completed
    Has Results
    • Neoplasms
    • Pancreatic Neoplasms
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 16, 2022

    Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma

    Active, not recruiting
    • Fallopian Tube Endometrioid Adenocarcinoma
    • +7 more
    • Anetumab Ravtansine
    • +2 more
    • Orange, California
    • +22 more
    Oct 22, 2022

    Pancreatic Cancer Trial in New Haven, New Brunswick, Nashville (anetumab ravtansine)

    Completed
    Has Results
    • Pancreatic Cancer
    • anetumab ravtansine
    • New Haven, Connecticut
    • +2 more
    Oct 11, 2021

    Pancreas Cancer, CAR-T Cell Therapy, Mesothelin Trial in Guangzhou (CAR-T cells)

    Recruiting
    • Pancreas Cancer
    • +3 more
    • CAR-T cells
    • Guangzhou, Guangdong, China
      The Second Affiliated Hospital of Guangzhou Medical University
    Mar 10, 2023

    Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7

    Active, not recruiting
    • Stage III Fallopian Tube Cancer AJCC v7
    • +14 more
    • Minneapolis, Minnesota
    • +1 more
    Jan 27, 2023

    Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Seattle (Autologous Mesothelin-specific

    Recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • Stage IV Pancreatic Cancer AJCC v8
    • Autologous Mesothelin-specific TCR-T Cells
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 31, 2023

    Pleural Malignant Mesothelioma Trial in Canada, United States (Anetumab Ravtansine, Laboratory Biomarker Analysis,

    Active, not recruiting
    • Pleural Malignant Mesothelioma
    • Anetumab Ravtansine
    • +3 more
    • Birmingham, Alabama
    • +32 more
    Dec 24, 2022

    Ovarian Cancer Trial in Hangzhou (mesothelin-specific chimeric antigen receptor T cell injection)

    Recruiting
    • Ovarian Cancer
    • mesothelin-specific chimeric antigen receptor T cell injection
    • Hangzhou, China
      First affiliated hospital, School of Medicine, Zhejiang Universi
    May 12, 2022

    Mesothelin Positive, Stage III NSCLC AJCC v7, Stage IIIA NSCLC AJCC v7 Trial in Phoenix, Jacksonville, Rochester (Anetumab

    Terminated
    Has Results
    • Mesothelin Positive
    • +4 more
    • Anetumab Ravtansine
    • +2 more
    • Phoenix, Arizona
    • +2 more
    Jan 5, 2023

    Asbestos Exposure Trial in Hamilton (Artichoke WPC)

    Completed
    • Asbestos Exposure
    • Artichoke WPC
    • Hamilton, Ontario, Canada
      St. Joseph's Hospital, Firestone Institute
    Jul 12, 2021

    Advanced Solid Tumors Trial in Worldwide (AMG 994, AMG 404)

    Active, not recruiting
    • Advanced Solid Tumors
    • AMG 994
    • AMG 404
    • Duarte, California
    • +16 more
    Nov 16, 2022

    Malignant Pleural Mesothelioma Trial in United States (Immunotherapy plus chemo, Immunotherapy with cyclophosphamide plus chemo)

    Completed
    Has Results
    • Malignant Pleural Mesothelioma
    • Immunotherapy plus chemotherapy
    • Immunotherapy with cyclophosphamide plus chemotherapy
    • San Francisco, California
    • +4 more
    Sep 28, 2020

    Advanced Cancers Associated With Mesothelin Expression Trial in United States (HPN536)

    Active, not recruiting
    • Advanced Cancers Associated With Mesothelin Expression
    • HPN536
    • Phoenix, Arizona
    • +15 more
    Sep 9, 2022

    Ovarian Cancer, Cholangiocarcinoma Recurrent, Mesothelioma, Malignant Trial (SynKIR-110, Autologous T cells Transduced with

    Not yet recruiting
    • Ovarian Cancer
    • +2 more
    • SynKIR-110, Autologous T cells Transduced with Mesothelin KIR-CAR
    • (no location specified)
    Oct 5, 2022

    Solid Tumor Trial in Shanghai (aPD1-MSLN-CAR T cells)

    Recruiting
    • Solid Tumor
    • αPD1-MSLN-CAR T cells
    • Shanghai, Shanghai, China
      Shanghai Mengchao Cancer Hospital
    Oct 24, 2022

    Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Trial in Canada,

    Active, not recruiting
    • Metastatic Pancreatic Adenocarcinoma
    • +5 more
    • Anetumab Ravtansine
    • +5 more
    • Birmingham, Alabama
    • +44 more
    Feb 2, 2023

    Lung Adenocarcinoma, Ovarian Cancer, Peritoneal Carcinoma Trial in Philadelphia (huCART-meso cells)

    Recruiting
    • Lung Adenocarcinoma
    • +5 more
    • huCART-meso cells
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Dec 1, 2022